Serostatus of IgG antibody against mumps virus in adult population of Al Madinah Al Munawarah, Saudi Arabia
- PMID: 34344810
- PMCID: PMC9195549
- DOI: 10.15537/smj.2021.42.8.20210228
Serostatus of IgG antibody against mumps virus in adult population of Al Madinah Al Munawarah, Saudi Arabia
Abstract
Objectives: To determine the frequency and distribution of mumps-specific IgG antibodies among the healthy adult Saudi population in Al Madinah Al Munawarah, Saudi Arabia, where mandatory vaccination against measles-mumps-rubella (MMR) has been implemented for 30 years.
Methods: Qualitative and quantitative indirect enzyme-linked immunosorbent assay was performed to determine the mumps IgG antibody levels in sera collected from 429 individuals, including 224 men and 205 women. Participants were stratified into 3 age groups according to vaccination history (<20, 21-30, and >31 years).
Results: The overall seroprevalence of mumps antibodies in our population was 79.0%. The highest proportion of individuals with IgG antibody seropositivity, at 87.8% (95% confidence interval (95% CI): 84.7%-90.8%), was observed among the <20 years age group, who received 2 doses of vaccine. No significant relationships were observed between mumps seropositivity and age group or gender. The multivariable analysis identified the male gender and the age group >31 years as factors associated with an increased likelihood of seronegativity. Al Madinah Al Munawarah has achieved increased anti-mumps antibody seroprevalence since the implementation of the 2-dose MMR vaccination schedule.
Conclusions: Based on our study findings, we recommend that serological screening be performed to assess the need for mumps vaccination among adults at high risk for exposure and transmission.
Keywords: immunity; mumps; seropositivity; seroprevalence; vaccination.
Copyright: © Saudi Medical Journal.
Figures



Similar articles
-
Rubella Humoral Immunity Among the Saudi Population of Madinah in the Western Region of Saudi Arabia.Viral Immunol. 2022 Jun;35(5):375-380. doi: 10.1089/vim.2021.0226. Epub 2022 May 10. Viral Immunol. 2022. PMID: 35537526
-
Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.J Med Virol. 2020 Aug;92(8):963-970. doi: 10.1002/jmv.25665. Epub 2020 Feb 3. J Med Virol. 2020. PMID: 31919861
-
Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.Hum Vaccin Immunother. 2021 Aug 3;17(8):2522-2529. doi: 10.1080/21645515.2021.1876486. Epub 2021 Feb 11. Hum Vaccin Immunother. 2021. PMID: 33573436 Free PMC article.
-
Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.Viral Immunol. 2016 Apr;29(3):159-63. doi: 10.1089/vim.2015.0070. Epub 2016 Feb 24. Viral Immunol. 2016. PMID: 26910764
-
Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.Arch Iran Med. 2013 Jan;16(1):38-41. Arch Iran Med. 2013. PMID: 23273235
Cited by
-
Exploring the Mumps Virus Glycoproteins: A Review.Viruses. 2022 Jun 18;14(6):1335. doi: 10.3390/v14061335. Viruses. 2022. PMID: 35746805 Free PMC article. Review.
References
-
- Mclean HQ, Hickman C, Seward JF.. Organization WH, Control CfD, Prevention. The immunological basis for immunization series: module 16: mumps. 2010.
-
- Davison P, Mumps Morris J.. StatPearls [Internet]: StatPearls Publishing; 2019.
-
- Ma R, Lu L, Zhou T, Pan J, Chen M, Pang X.. Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016. Vaccine 2018; 36: 2589–2595. - PubMed
-
- Lane TM, Hines J.. The management of mumps orchitis. BJU Int 2006; 97: 1–2. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical